Categories: News

LBB Specialties and DMC Biotechnologies Partner to Bring Fermented Inositols to the U.S. Market

NORWALK, Conn., April 7, 2026 /PRNewswire/ — LBB Specialties (LBBS), a North American distributor of specialty chemicals and ingredients providing technical solutions with a customer-first approach, today announced a new partnership with DMC Biotechnologies (DMC), a U.S.-based ingredient supplier pioneering sustainable fermentation technologies. Through this agreement, LBB Specialties will serve as the distributor of DMC’s KeyPura™ fermented myo-inositol and D-chiro-inositol in the United States and Canada — two next-generation ingredients produced through precision fermentation — serving the Human Nutrition, Food, Personal Care, and Life Science markets.

- Advertisement -

“This collaboration brings to market a cleaner, more sustainable, and more reliable source of inositols. As essential compounds, inositols play critical roles in hormonal balance, reproductive health, infant brain development, blood sugar regulation with improved insulin sensitivity, and overall metabolic health,” said Jerry Whelan, Senior Vice President, Food & Nutrition at LBBS. “DMC leverages their proprietary precision fermentation technology to produce bio-identical ingredients without solvents, with greater purity and consistency, and with a significantly lower environmental footprint than traditional chemical production methods.”

- Advertisement -

“Together, LBBS and DMC are shaping the future of ingredient innovation,” said Rusty Pittman, Vice President of Business Development at DMC. “This partnership underscores our shared commitment to high-purity, naturally derived ingredients with proven health benefits – responsibly sourced and sustainably produced. The partnership further strengthens LBBS’s growing portfolio of functional and sustainable ingredient technologies that empower brands to meet the next generation of consumer expectations, without compromising performance, purity, or planet.”

- Advertisement -

For more information about DMC’s KeyPura™ fermented inositols, please contact LBB Specialties today.

- Advertisement -

About LBB Specialties

- Advertisement -

LBB Specialties (LBBS) is a dedicated provider of specialty chemicals and ingredients, specializing in sales, marketing, and distribution across North America. LBBS provides technical solutions with a customer-first approach, serving diverse end-markets through five industry and market business units: Care, Food & Nutrition, Industrial Specialties, Life Sciences, and Canada. www.LBBSpecialties.com

- Advertisement -

Media Contact:
Ahmed Hanafy
media@lbbspecialties.com

- Advertisement -

About DMC Biotechnologies

- Advertisement -

DMC Biotechnologies is a U.S.-based biomanufacturer redefining how the world produces specialty chemicals and ingredients. Through precision fermentation and synthetic biology, DMC creates sustainable, bio-based alternatives that reduce carbon emissions, enhance quality, and improve global supply chain resilience. The company’s proprietary Dynamic Metabolic Control™ platform enables predictable, scalable, and efficient fermentation processes that unlock a new era of low-impact ingredient manufacturing. Learn more at www.dmcbio.com

- Advertisement -

Media Contact:
Megan Hopkins
media@dmcbio.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/2537440/LBB_Specialties_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/lbb-specialties-and-dmc-biotechnologies-partner-to-bring-fermented-inositols-to-the-us-market-302736205.html

- Advertisement -

Recent Posts

TBoostExperts.com Announces Availability of 2026 Consumer Report on Testosterone Booster Supplements and Mens Health Supplement Evaluation

NEW YORK,USA, June 27, 2026 (GLOBE NEWSWIRE) -- TBoostExperts.com today announced the availability of its…

11 hours ago

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreichs Ataxia

June 26, 2026 16:05 ET  | Source: Larimar Therapeutics Webcast on Monday, June 29, 2026,…

11 hours ago

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

WILMETTE, Ill., June 26, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”)…

11 hours ago

“UK-India Free Trade Agreement will be India’s most comprehensive agreement so far”: Piyush Goyal at UK-India Week 2026

Capital & Future Frontiers Forum brings together senior ministers, CEOs, investors and innovators to chart…

13 hours ago

From Student to Contributor: Zaggle Founder Announces 4 Crore Upgrade for Kulachi Hansraj Model School

One of the Largest Alumni-Led Contributions in DAV's 132-Year History to Strengthen Education, Infrastructure and…

13 hours ago

HDFC ERGO Highlights the Importance of Comprehensive Car Insurance for Todays Vehicle Owners

Mumbai, Maharashtra, June 27, 2026 (GLOBE NEWSWIRE) -- Today’s vehicle owners face rising repair costs,…

15 hours ago